Column Group II GP, LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 63,768 shares at $13.88 ($885K) on 2019-07-12, disclosed to the SEC on 2019-07-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.87 | 10,870 | $151K | 17.0% |
| 2 | $13.87 | 10,870 | $151K | 17.0% |
| 3 | $13.88 | 21,014 | $292K | 33.0% |
| 4 | $13.88 | 21,014 | $292K | 33.0% |
| Total | $13.88 avg | 63,768 | $885K | 100% |
| Filing → |
| NGM | BUY | 2020-08-03 | $13K | — | Filing → |
| NGM | BUY | 2019-05-09 | $804K | — | Filing → |
| IMDZ | BUY | 2016-09-22 | $5.0M | — | Filing → |